A Study of the Effectiveness of Additional Risk Minimization Measures Related to ARAVA® (Leflunomide) in Saudi Arabia

NCT06714461 · clinicaltrials.gov ↗

ACTIVE_NOT_RECRUITING

Status

3500

Enrollment

INDUSTRY

Sponsor class

Conditions

Rheumatoid Arthritis
Psoriatic Arthritis

Interventions

DRUG: Leflunomide

Sponsor

Sanofi